Alternative Processing of Amyloid Precursor Protein in Alzheimer’s Disease
Start Date
6-12-2024 12:00 PM
End Date
6-12-2024 1:30 PM
COinS
Dec 6th, 12:00 PM
Dec 6th, 1:30 PM
Alternative Processing of Amyloid Precursor Protein in Alzheimer’s Disease
Author Bio
Dr. Gregg B. Fields received his B.S. and Ph.D. degrees in chemistry from the University of Florida and Florida State University, respectively, and was a Postdoctoral Scholar with Professor Ken A. Dill at the University of California at San Francisco. Dr. Fields joined FAU in 2014 as a Full Professor and the Chair in the Department of Chemistry & Biochemistry. In 2019 he was appointed as Executive Director of the Institute for Human Health & Disease Intervention (I-HEALTH) at FAU and in 2021 became the Co-Director of the Memorial Cancer Institute Florida Atlantic University (MCIFAU) Cancer Center of Excellence, and in 2023 was appointed Interim Vice President for Research at FAU. The Fields research group has focused on extracellular protease-based diseases, with particular attention paid to tumor metastasis, arthritis, and neurodegenerative diseases.
Dr. Fields is an elected Fellow of the National Academy of Inventors (NAI) and the American Association for the Advancement of Science (AAAS). He has authored or coauthored more than 330 scientific publications and has presented more than 250 invited lectures.